- The program focuses on antibiotic resistance in urinary tract infections (UTI-DR), with ap...
* Dr. Jong-Yoon Chun, Chairman and CEO of Seegene, highlights progress toward fully automated and...
* Fully Unmanned— CURECA™, the 100% Automated Diagnostic System Defining the Future Gold Standard,...
* Real-time analytics that empower clinical decision-making and pandemic preparedness * Global ...
* Seegene previews a concept video of CURECATM at ESCMID Global 2025, ahead of its anticipated de...
- Seegene to showcase a conceptual video introducing CURECA™ at ESCMID Global 2025 — a full automat...
- Presented a roadmap to enhance screening reliability at the world's leading multidisciplinary ...
In the news release, Seegene Holds Partner Executive Roundtable with Microsoft, and Springer Nature...
* Werfen, a worldwide leader in specialized diagnostics, becomes the first European company to fi...
* Introduces Novaplex™ MPXV/OPXV plus Assay (RUO) that is designed to detect Clade I, which has hi...
- Nature Awards MDx Impact Grants in partnership with Seegene extends commitment to external innov...
- Develops NovaplexTM MPXV/OPXV Assay and NovaplexTM HSV-1&2/VZV/MPXV Assay - Designed to detect ...
- Exhibited multiplex PCR testing technologies that provide comprehensive results from a single te...
* Showcases Allplex™ HPV products designed to test for 14 high-risk HPV genotypes * Advocates...
- Strategic alliance aims to foster collaboration with researchers working in various disease field...
* Two CEOs met at Seegene headquarters to discuss and concurred with Seegene's vision * Seegene...
* 26 submissions selected from a total of 281 applications from 47 countries to diagnose infectio...
* Strategic collaboration to open a new chapter in the field of molecular diagnostics that aspire...
SEOUL, South Korea, Dec. 27, 2023 /PRNewswire/ -- Seegene Inc. (KQ096530), a leading South Korean c...
Company attributes B+ rating to progress related to its Human Rights Management Declaration, eco-fr...